Yahoo Italia Ricerca nel Web

Risultati di ricerca

1. stockanalysis.com › stocks › rnaAvidity Biosciences, Inc. (RNA) - Stock Analysis

   stockanalysis.com › stocks › rna

   • Cache

   3 giorni fa · Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat diseases previously untreatable with RNA therapeutics.

2. www.finsmes.com › 2024 › 07GRO Biosciences Closes $60.3M Series B Financing

   www.finsmes.com › 2024 › 07

   • Cache

   5 giorni fa · GRO Biosciences, a Cambridge, MA-based biotechnology company leveraging synthetic biology, raised $60.3M in Series B funding. The round, which brought the total amount to more than $90M, was led...

3. seekingalpha.com › symbol › NBIXNBIX Neurocrine Biosciences, Inc. - Seeking Alpha

   seekingalpha.com › symbol › NBIX

   • Cache

   4 giorni fa · A high-level overview of Neurocrine Biosciences, Inc. (NBIX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

   • Company name: Incyte Corporation
   • Settore: Biotechnology

   • Dipendenti: 2,524
   • Market Cap: 13.63B

4. simplywall.st › nasdaq-hrmy › harmony-biosciences-holdingsHarmony Biosciences Holdings NasdaqGM:HRMY Stock Report - Simply...

   simplywall.st › nasdaq-hrmy › harmony-biosciences-holdings

   • Cache

   4 giorni fa · A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. About the company. Rewards. Trading at 92.8% below our estimate of its fair value. Earnings are forecast to grow 31.7% per year.

   • 52 Week High: US$39.27
   • Beta: 0.72

   • 52 Week Low: US$18.61
   • Current Share Price: US$30.08

5. stockanalysis.com › stocks › drugBright Minds Biosciences Inc. (DRUG) - Stock Analysis

   stockanalysis.com › stocks › drug

   • Cache

   3 giorni fa · Get a real-time Bright Minds Biosciences Inc. (DRUG) stock price quote with breaking news, financials, statistics, charts and more.

   • EPS (ttm): 0.99
   • Net Income (ttm): 3.86M

   • Market Cap: 4.64M
   • Shares Out: 4.46M

6. www.bloomberg.com › quote › NBIX:USNBIX: Neurocrine Biosciences Inc Stock Price Quote - Bloomberg

   www.bloomberg.com › quote › NBIX:US

   • Cache

   3 giorni fa · Stock analysis for Neurocrine Biosciences Inc (NBIX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

7. simplywall.st › otc-evlo › evelo-biosciencesEvelo Biosciences OTCPK:EVLO Stock Report - Simply Wall St

   simplywall.st › otc-evlo › evelo-biosciences

   • Cache

   4 giorni fa · Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects.